LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Aguiar Soares, Rodrigo Dian De Oliveira ^a   Roatt, Bruno Mendes ^a   Ker, Henrique Gama ^a   Moreira, Nádia Das Dores ^a   Mathias, Fernando Augusto Siqueira ^a   Cardoso, Jamille Mirelle De Oliveira ^a   Gontijo, Nelder Figueiredo ^b   Bruna Romero, Oscar ^b   Teixeira Carvalho, Andréa ^c   Martins Filho, Olindo Assis ^c   Corrêa Oliveira, Rodrigo ^c   Giunchetti, Rodolfo Cordeiro ^b   Reis, Alexandre Barbosa ^a,d  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Institute of Science and Technology of Tropical Diseases   (Brazil)

Author keywords

Canine visceral leishmaniasis; Experimental challenge; Immunogenicity; LBSapSal vaccine; Leishmania infantum; Saliva of Lutzomyia longipalpis

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; LEISHMANIA BRAZILIENSIS ANTIGEN; LEISHMANIA VACCINE; NITRIC OXIDE; PARASITE ANTIGEN; SALIVA PROTEIN; SAPONIN; UNCLASSIFIED DRUG; PROTOZOON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD5+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ANTIGENICITY; FEMALE; FOLLOW UP; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LUTZOMYIA LONGIPALPIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; PARASITISM; PROMASTIGOTE; REDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VISCERAL LEISHMANIASIS; ANIMAL; DOG; DOG DISEASES; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; PARASITOLOGY; PHYSIOLOGY; PSYCHODIDAE; SALIVARY GLAND; VETERINARY;

CANIS FAMILIARIS; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LUTZOMYIA LONGIPALPIS; PHLEBOTOMINAE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOG DISEASES; DOGS; FEMALE; LEISHMANIA INFANTUM; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MALE; PSYCHODIDAE; SALIVARY GLANDS;

EID: 84893712790     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-61     Document Type: Article

References (58)

1. Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods. Coura-Vital W, Marques MJ, Veloso VM, Roatt BM, Aguiar-Soares RD, Reis LE, Braga SL, Morais MH, Reis AB, Carneiro M, PLoS Negl Trop Dis 2011 5 8 1291 10.1371/journal.pntd.0001291 21858243
2. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Alvar J, Molina R, San Andres M, Tesouro M, Nieto J, Vitutia M, González F, San Andrés MD, Boggio J, Rodriguez F, et al. Ann Trop Med Parasitol 1994 88 371 378 7979624
3. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J, Trends Parasitol 2010 26 7 341 349 Review 10.1016/j.pt.2010.04.005 20488751
4. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Lemesre JL, Holzmuller P, Cavaleyra M, Goncalves RB, Hottin G, Papierok G, Vaccine 2005 23 2825 2840 10.1016/j.vaccine.2004.11.061 15780731
5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomized efficacy field trial. Lemesre JL, Holzmuller P, Goncalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G, Vaccine 2007 25 4223 4234 10.1016/j.vaccine.2007.02.083 17395339
6. Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis. Fujiwara RT, Vale AM, França da Silva JC, da Costa RT, Quetz Jda S, Martins Filho OA, Reis AB, Corrêa Oliveira R, Machado-Coelho GL, Bueno LL, Bethony JM, Frank G, Nascimento E, Genaro O, Mayrink W, Reed S, Campos-Neto A, Vet Res 2005 36 827 838 10.1051/vetres:2005033 16120256
7. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Borja-Cabrera GP, Correia Pontes NN, da Silva VO, de Souza Paraguai E, Santos WR, Gomes EM, Luz KG, Palatnik M, Palatnik de Sousa CB, Vaccine 2002 20 3277 3284 10.1016/S0264-410X(02)00294-3 12213397
8. Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Borja-Cabrera GP, Santos FN, Bauer FS, Parra LE, Menz I, Morgado AA, Soares IS, Batista LM, Palatnik-de-Sousa CB, Vaccine 2008 26 4991 4997 10.1016/j.vaccine.2008.07.029 18675868
9. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Fernandes AP, Costa MM, Coelho EA, Michalick MS, de Freitas E, Melo MN, Luiz Tafuri W, Resende Dde M, Hermont V, Abrantes Cde F, Gazzinelli RT, Vaccine 2008 26 5888 5895 10.1016/j.vaccine.2008.05.095 18786587
10. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Mayrink W, Genaro O, Silva JC, da Costa RT, Tafuri WL, Toledo VP, da Silva AR, Reis AB, Williams P, da Costa PW, Mem Inst Oswaldo Cruz 1996 91 695 697 9283646
11. A Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. Lasri S, Sahibi H, Sadak A, Jaffe CL, Rhalem A, Vet Res 1999 30 441 449 10543378
12. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. Panaro MA, Acquafredda A, Lisi S, Lofrumento DD, Mitolo V, Sisto M, Fasanella A, Trotta T, Bertani F, Consenti B, Brandonisio O, Comp Immunol Microbiol Infect Dis 2001 24 187 195 10.1016/S0147-9571(00) 00026-6 11440191
13. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Giunchetti RC, Correa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Roatt BM, de Oliveira Aguiar-Soares RD, de Souza JV, das Dores Moreira N, Malaquias LC, Mota e Castro LL, de Lana M, Reis AB, Vaccine 2007 25 7674 7686 10.1016/j.vaccine.2007.08.009 17913311
14. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Giunchetti RC, Correa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Roatt BM, de Oliveira Aguiar-Soares RD, Coura-Vital W, de Abreu RT, Malaquias LC, Gontijo NF, Brodskyn C, de Oliveira CI, Costa DJ, de Lana M, Reis AB, Vaccine 2008 26 623 638 10.1016/j.vaccine. 2007.11.057 18180079
15. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis. Giunchetti RC, Reis AB, da Silveira-Lemos D, Martins-Filho OA, Correa- Oliveira R, Bethony J, Vale AM, da Silva Quetz J, Bueno LL, França-Silva JC, Nascimento E, Mayrink W, Fujiwara RT, Res Vet Sci 2008 85 106 112 10.1016/j.rvsc.2007.09.008 17950391
16. The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. Carcelen J, Iniesta V, Fernandez-Cotrina J, Serrano F, Parejo JC, Corraliza I, Gallardo-Soler A, Marañón F, Soto M, Alonso C, Gómez-Nieto C, Vaccine 2009 27 5964 5973 10.1016/j.vaccine.2009.07.069 19666153
17. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs. Fiuza JA, Santiago Hda C, Selvapandiyan A, Gannavaram S, Ricci ND, Bueno LL, Bartholomeu DC, Correa-Oliveira R, Nakhasi HL, Fujiwara RT, Vaccine 2013 31 14 1785 1792 10.1016/j.vaccine.2013.01.048 23398933
18. Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs. Moreno J, Vouldoukis I, Martin V, McGahie D, Cuisinier AM, Gueguen S, PLoS Negl Trop Dis 2012 6 6 1683 10.1371/journal.pntd.0001683 22724031
19. Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis. Ravindran R, Ali N, Curr Mol Med 2004 4 6 697 709 10.2174/1566524043360212 15357218
20. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R, Vaccine 2004 22 4097 4100 10.1016/j.vaccine.2004.03.058 15364462
21. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Titus RG, Ribeiro JM, Science 1988 239 4845 1306 1308 10.1126/science.3344436 3344436
22. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. Samuelson J, Lerner E, Tesh R, Titus R, J Exp Med 1991 173 1 49 54 10.1084/jem.173.1.49 1985126
23. Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Warburg A, Saraiva E, Lanzaro GC, Titus RG, Neva F, Philos Trans R Soc B 1994 345 1312 223 230 10.1098/rstb.1994.0097
24. Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Lima HC, Titus RG, Infect Immun 1996 64 12 5442 5445 8945606
25. Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. de Moura TR, Oliveira F, Novais FO, Miranda JC, Clarêncio J, Follador I, Carvalho EM, Valenzuela JG, Barral-Netto M, Barral A, Brodskyn C, de Oliveira CI, PLoS Negl Trop Dis 2007 1 84 10.1371/journal.pntd.0000084 18060088
26. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva pre-exposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL, J Exp Med 1998 188 10 1941 1953 10.1084/jem.188.10.1941 9815271
27. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D, Science 2000 290 5495 1351 1354 10.1126/science.290.5495.1351 11082061
28. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, de Oliveira CI, Miranda JC, Elnaiem DE, Kamhawi S, Valenzuela JG, Brodskyn CI, Proc Natl Acad Sci U S A 2008 105 7845 7850 10.1073/pnas.0712153105 18509051
29. Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, Ward JM, Elnaiem DE, Fischer L, Valenzuela JG, Kamhawi S, PLoS Pathog 2009 5 5 1000441 10.1371/journal.ppat.1000441 19461875
30. A simple technique for mass rearing Lutzomyia longipalpis and Phlebotomus papatasi (Diptera: Psychodidae) in the laboratory. Modi GB, Tesh RB, J Med Entomol 1983 20 5 568 569 6644754
31. Anti-complement activity in the saliva of phlebotomine sand flies and other haematophagous insects. Cavalcante RR, Pereira MH, Gontijo NF, Parasitology 2003 127 1 87 93 10.1017/S0031182003003329 12885192
32. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation. Roatt BM, Aguiar-Soares RD, Vitoriano-Souza J, Coura-Vital W, Braga SL, Corrêa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, de Lana M, Figueiredo Gontijo N, Marques MJ, Giunchetti RC, Reis AB, PLoS One 2012 7 11 49780 10.1371/journal.pone.0049780 23189161
33. Experimental infection of dogs with Leishmania and saliva as a model to study canine visceral leishmaniasis. Costa DJ, Carvalho RM, Abbehusen M, Teixeira C, Pitombo M, Trigo J, Nascimento F, Amorim L, Abreu-Silva AL, do Socorro Pires Cruz M, Miranda JC, Fukutani K, de Oliveira CI, Barral A, Barral-Netto M, Brodskyn C, PLoS One 2013 8 4 60535 10.1371/journal.pone.0060535 23577121
34. Development of eosinophilia in dogs intradermically inoculated with sand fly saliva and Leishmania (Leishmania) chagasi stationary-phase promastigotes. Paranhos M, dos Santos WC, Sherlock I, Oliveira GG, de Carvalho LC, Mem Inst Oswaldo Cruz 1993 88 2 249 251 10.1590/S0074-02761993000200012 8107586
35. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Carvalho MG, Mayrink W, França-Silva JC, Giunchetti RC, Genaro O, Corrêa-Oliveira R, Res Vet Sci 2006 81 68 75 10.1016/j.rvsc.2005.09.011 16288789
36. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, Rivollet D, Vidaud M, Deniau M, Clin Diagn Lab Immunol 2001 8 828 831 11427436
37. Parasite burden in hamsters infected with two different strains of Leishmania (Leishmania) infantum: «Leishman Donovan Units» versus real-time PCR. Moreira ND, Vitoriano-Souza J, Roatt BM, Vieira PMA, Ker HG, de Oliveira Cardoso JM, Giunchetti RC, Carneiro CM, de Lana M, Reis AB, PLoS One 2012 10 1371 journal.pone.0047907
38. The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission. Titus RG, Bishop JV, Mejia JS, Parasite Immunol 2006 28 4 131 141 16542315
39. Vaccines in leishmaniasis: advances in the last five years. Brodskyn C, de Oliveira CI, Barral A, Barral-Netto M, Expert Rev Vaccines 2003 2 5 705 717 10.1586/14760584.2.5.705 14711330
40. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Kamhawi S, Microbes Infect 2000 2 14 1765 1773 10.1016/S1286-4579(00)01331-9 11137049
41. Is it possible to develop panarthropod vaccines? Mejia JS, Bishop JV, Titus RG, Trends Parasitol 2006 22 8 367 370 10.1016/j.pt.2006.06.001 16784890
42. Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis. Araújo MS, de Andrade RA, Sathler-Avelar R, Magalhães CP, Carvalho AT, Andrade MC, Campolina SS, Mello MN, Vianna LR, Mayrink W, Reis AB, Malaquias LC, Rocha LM, Martins-Filho OA, Vet Immunol Immunopathol 2011 141 1-2 64 75 10.1016/j.vetimm.2011.02.007 21439654
43. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune. Araujo MS, de Andrade RA, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Vianna LR, Mayrink W, Reis AB, Malaquias LC, Mello MN, Martins-Filho OA, Vaccine 2009 27 1008 1017 10.1016/j.vaccine.2008.11.104 19110023
44. Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation. Day MJ, Vet Parasitol 2007 147 2 8 10.1016/j.vetpar.2007.03.037 17467176
45. Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. Araujo MS, de Andrade RA, Vianna LR, Mayrink W, Reis AB, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Mello MN, Martins-Filho OA, Vaccine 2008 26 2211 2224 10.1016/j.vaccine.2008.02.044 18395948
46. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Reis AB, Teixeira-Carvalho A, Giunchetti RC, Guerra LL, Carvalho MG, Mayrink W, Genaro O, Corrêa-Oliveira R, Martins-Filho OA, Clin Exp Immunol 2006 146 303 311 10.1111/j.1365-2249.2006.03206.x 17034583
47. Systemic and compartmentalized immune response in canine visceral leishmaniasis. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM, Mayrink W, Tafuri WL, Corrêa-Oliveira R, Vet Immunol Immunopathol 2009 128 87 95 10.1016/j.vetimm.2008.10.307 19054576
48. Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis. Giunchetti RC, Martins-Filho OA, Carneiro CM, Mayrink W, Marques MJ, Tafuri WL, Correa-Oliveira R, Reis AB, Vet Immunol Immunopathol 2008 121 23 33 10.1016/j.vetimm.2007.07.009 17723246
49. A canine CD8+ cytotoxic T-cell line specific for Leishmania infantum infected macrophages. Pinelli E, Boog CJ, Rutten VP, Van DB, Bernadina WE, Ruitenberg EJ, Tissue Antigens 1994 43 189 192 10.1111/j.1399-0039.1994.tb02321. x 8091417
50. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, Del Real G, Ruitenberg J, Infect Immun 1994 62 229 235 8262632
51. Cytokines in canine visceral leishmaniasis. Pinelli E, Cytokines in veterinary medicine Netherlands: Utrecht University, Schijns HM, 1997 217 247
52. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, Del Real G, Ruitenberg J, Eur J Immunol 1995 25 1594 1600 10.1002/eji.1830250619 7614987
53. +) antigen-specific T cells. Mary C, Auriault V, Faugere B, Dessein AJ, Infect Immun 1999 67 5559 5566 10531200
54. Detailed analysis of an experimental challenge model for Leishmania infantum (Jpc strain) in dogs. Poot J, Rogers ME, Bates PA, Vermeulen A, Vet Parasitol 2005 130 1-2 41 53 15893068
55. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D, Science 2008 321 970 974 10.1126/science.1159194 18703742
56. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL, PLoS Pathog 2009 5 1000484 10.1371/journal.ppat.1000484 19543375
57. Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Manna L, Reale S, Viola E, Vitale F, Foglia Manzillo V, Pavone LM, Caracappa S, Gravino AE, Vet Parasitol 2006 142 271 280 10.1016/j.vetpar.2006.06.028 16920264
58. Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Alves CF, de Amorim IF, Moura EP, Ribeiro RR, Michalick MS, Kalapothakis E, Bruna-Romero O, Tafuri WL, Teixeira MM, Melo MN, Vet Immunol Immunopathol 2009 128 343 349